ILLUMINA INC (ILMN)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ILMN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ILMN | Chief Executive Officer | 50 | ["Chief Executive Officer, Illumina","SVP, President of Life Sciences & Applied Markets Group, Agilent Technologies","SVP, President of Diagnostics & Genomics Group, Agilent Technologies"] | [] | 2026 |
Biography sourced from the proxy statement filing.
Chief Executive Officer Profile Director since 2023 Age: 50 Board Committees None Education M. Sc. In Physics from the Technical University of Denmark Ph.D. in Physics from the Technical University of Denmark Relevant Expertise Mr. Thaysen s extensive background and experience in genomics and life sciences fits closely with Illumina s mission. His experience provides the Company and the Board with a unique combination of deep technological and commercial experience, which is critical to driving profitable growth and creating value for all of Illumina s stakeholders. Career Highlights Chief Executive Officer, Illumina, Inc. (since 2023) SVP, President of Life Sciences & Applied Markets Group at Agilent Technologies (2018 2023); SVP, President of Diagnostics & Genomics Group (2014 2018); VP, General Manager, Diagnostics & Genomics (2013 2014) Corporate Vice President, R&D at Dako, a Danish cancer diagnostic company acquired by Agilent in 2012 (2010 2013) Of Note Chair, ALDA (Analytical, Life Science & Diagnostics Association) (since 2023) Founder and Chief Technology Officer at Cantion, a research and defense application development company (2001)